February 15, 2024 C-Path Launches Revamped Website to Enhance Collaborations in Drug Development Critical Path Institute (C-Path) today officially launched its newly revamped website, designed to further enhance collab...
February 7, 2024 Dr. Janet Woodcock: A Visionary Leader in Regulatory Science and the Inspirational Force behind the Creation of Critical Path Institute In her nearly four decades with the U.S. Food and Drug Administration, Dr. Janet Woodcock personally transformed the culture of...
February 1, 2024 FamilieSCN2A Partners with C-Path’s RDCA-DAP, Advancing Research Efforts for SCN2A-Related Disorders n a significant step to enhance research efforts for SCN2A-related autism and epilepsy, Critical Path Institute (C-Path) and Famil
January 25, 2024 C-Path Promotes Cécile Ollivier to Vice President of Global Affairs, Expanding Leadership in Drug Development Critical Path Institute (C-Path) today announced the promotion of Cécile Ollivier, M.S., from Managing Director, Europe to...
C-Path, CPP Share Manuscript That Redefines Parkinson’s Disease C-Path and its Critical Path for Parkinson’s Consortium are pleased to share a new manuscript that redefines Parkinson’s...
December 21, 2023 Flexible approaches to eCOA administration in clinical trials: The site perspective The Critical Path Institute convened the Support Flexible Approaches to PRO Data Collection project as part of the eCOA: Gettin
C-Path Partners with Unite4TB to Create a New Dawn in the Fight Against Tuberculosis C-Path is proud to be part of UNITE4TB, a public-private partnership funded by the Innovative Medicines Initiative and part of the
ASN PKDOC Poster — November 2023: Despite the regulatory advances in ADPKD including the qualification of total kidney volume (TKV) as a prognostic enrichment bioma
eCOA Consortium Announces Publication of an Open Access Article C-Path’s eCOA Consortium is pleased to announce the publication of an open access article in Value in Health titled “Best Prac